Integrated Technology Platforms

With the application of Smart Design to drug discovery, Genhouse Bio has built a streamlining and modularizing system of drug development and intergrated technology platforms for drug design, evaluation and optimization. with these platforms, Genhouse is able to speed up drug development and improve the efficiency of lead identification.

  • Translational Medicine

    Biomarkers, as one of the most effective diagnostic tools in cancer, are extremely important in cancer diagnosis, treatment and prognosis. The translational medicine platform of Genhouse uses biomarkers to drive original innovation—search for suitable biomarkers to identify novel targets with prominent therapeutic potential and more precisely guide the patient stratification and efficacy evaluation in clinical development.

  • CADD+

    Computer-Aided Drug Design (CADD) Platform is a method based on quantum mechanics and molecular dynamics of molecular mechanics to predict drug-target interaction for drug design, screening and optimization. The CADD team of Genhouse has accumulated plentiful experience in structure-based drug design (i.e. molecular docking, virtual screening, scaffold hopping, de novo drug design, homology modeling, conformational analysis and quantum chemical calculation), ligand-based drug design (i.e. pharmacophore mapping and QSAR analysis) and prediction of physicochemical and DMPK properties. Meanwhile, through collaboration with artificial intelligence drug design companies, Genhouse is actively applying deep learning to assist drug design, expand drug discovery methods and improve the efficiency of drug development.

  • Structural Biology

    Structural biology is the field of biology that studies protein structure and structure-activity relationship. Genhouse has built a robust technology platform for protein expression, purification and crystallization. Through the collaboration with National Center for Protein Science Shanghai, Genhouse has gained the capability to illustrate the molecular mechanism behind drug-target interaction, which serves as the cornerstone for rational drug design.

  • Druggability Optimization

    The druggability of drug candidates is consist of druglikeness, physicochemistry, biochemistry, pharmacokinetics and toxicity. As new drug development requires extensive time and investment, performing druggability evaluation in parallel with early-stage drug design and SAR research is a powerful means to lower risk. Genhouse applies the concept of Smart Design, utilizes both SAR and SPR optimization to improve the efficiency of drug development.

  • Efficacy Evaluation

    Genhouse has systematically built various in vitro/in vivo efficacy models with international standards to evaluate preclinical efficacy of drug candidates with different MoAs using CDX, PDX and syngeneic models. The efficacy evaluation platform is able to provide solid evidence of efficacy and safety to steer clinical development.

Privacy Statement

Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.

Personal Information Collected by Genhouse

When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.

Information Disclosures and Sharing

Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.

We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.

We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.


We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.

Links to Other Websites

If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.

Contact Information

If you have any questions about our Privacy Statement, please do not hesitate to contact us at [].

Effective and Last Updated: April 15th 2021